A longstanding research goal has been to understand the nature and role of copper–oxygen intermediates within copper-containing enzymes and abiological catalysts. Synthetic chemistry has played a pivotal role in highlighting the viability of proposed intermediates and expanding the library of known copper–oxygen cores. In addition to the number of new complexes that have been synthesized since the previous reviews on this topic in this journal (Mirica, L. M.; Ottenwaelder, X.; Stack, T. D. P. Chem. Rev. 2004, 104, 1013–1046 and Lewis, E. A.; Tolman, W. B. Chem. Rev. 2004, 104, 1047–1076), the field has seen significant expansion in the (1) range of cores synthesized and characterized, (2) amount of mechanistic work performed, particularly in the area of organic substrate oxidation, and (3) use of computational methods for both the corroboration and prediction of proposed intermediates. The scope of this review has been limited to well-characterized examples of copper–oxygen species but seeks to provide a thorough picture of the spectroscopic characteristics and reactivity trends of the copper–oxygen cores discussed.
In a possibly biomimetic fashion, formally copper(III)–oxygen complexes LCu(III)–OH (1) and LCu(III)–OOCm (2) (L2– = N,N′-bis(2,6-diisopropylphenyl)-2,6-pyridinedicarboxamide, Cm = α,α-dimethylbenzyl) have been shown to activate X–H bonds (X = C, O). Herein, we demonstrate similar X–H bond activation by a formally Cu(III) complex supported by the same dicarboxamido ligand, LCu(III)–O2CAr1 (3, Ar1 = meta-chlorophenyl), and we compare its reactivity to that of 1 and 2. Kinetic measurements revealed a second order reaction with distinct differences in the rates: 1 reacts the fastest in the presence of O–H or C–H based substrates, followed by 3, which is followed by (unreactive) 2. The difference in reactivity is attributed to both a varying oxidizing ability of the studied complexes and to a variation in X–H bond functionalization mechanisms, which in these cases are characterized as either a hydrogen-atom transfer (HAT) or a concerted proton-coupled electron transfer (cPCET). Select theoretical tools have been employed to distinguish these two cases, both of which generally focus on whether the electron (e–) and proton (H+) travel “together” as a true H atom, (HAT), or whether the H+ and e– are transferred in concert, but travel between different donor/acceptor centers (cPCET). In this work, we reveal that both mechanisms are active for X–H bond activation by 1–3, with interesting variations as a function of substrate and copper functionality.
A series of complexes {[NBu4][LCuII(O2CR)] (R = −C6F5, −C6H4(NO2), −C6H5, −C6H4(OMe), −CH3, and −C6H2( i Pr)3)} were characterized (with the complex R = −C6H4(m-Cl) having been published elsewhere (J. Am. Chem. Soc.201914117236)). All feature N,N′,N″-coordination of the supporting L2– ligand, except for the complex with R = −C6H2( i Pr)3, which exhibits N,N′,O-coordination. For the N,N′,N″-bound complexes, redox properties, UV–vis ligand-to-metal charge transfer (LMCT) features, and rates of hydrogen atom abstraction from 2,4,6,-tri-t-butylphenol using the oxidized, formally Cu(III) compounds LCuIII(O2CR) correlated well with the electron donating nature of R as measured both experimentally and computationally. Specifically, the greater the electron donation, the lower is the energy for LMCT and the slower is the reaction rate. The results are interpreted to support an oxidatively asynchronous proton-coupled electron transfer mechanism that is sensitive to the oxidative power of the [CuIII(O2CR)]2+ core.
The addition of 1 equiv of KO 2 and Kryptofix222 (Krypt) in CH 3 CN to a solution of LCu(CH 3 CN) [L = N,N′-bis(2,6-diisopropylphenyl)-2,6-pyridinecarboxamide] in tetrahydrofuran at −80 °C yielded [K(Krypt)][LCuO 2 ], the enhanced stability of which enabled reexamination of its reactivity with 2-phenylpropionaldehyde (2-PPA). Mechanistic and product analysis studies revealed that [K(Krypt)][LCuO 2 ] reacts with wet 2-PPA to form [LCuOH] − , which then, deprotonates 2-PPA to yield the copper(II) enolate complex [LCu(OC=C(Me)Ph)] − . Acetophenone was observed upon workup of this complex or mixtures of KO 2 and 2-PPA alone, in support of an alternative mechanism(s) to the one proposed previously involving an initial nucleophilic attack at the carbonyl group of 2-PPA.Elucidating the structure and function of putative monocopper−oxygen intermediates is imperative for understanding many oxygenase enzymes 1 and abiological oxidation catalysts. 2 Common to all mechanistic schemes for the activation of O 2 in such systems is the initial formation of a 1:1 Cu/O 2 species, typically formulated as a copper(II) superoxide comprising a [CuO 2 ] + core. 3 Significant appreciation of the structures and spectroscopic properties of [CuO 2 ] + cores has been achieved through studies of synthetic complexes. 4 Some features of the reactivity of such complexes also have been examined, but many questions concerning detailed mechanisms, supporting ligand effects, 5 and other aspects remain unanswered because of their thermal instability, challenges associated with isolating the complexes in pure form, and complicated side reactions.
Computational screening of a series of aluminum complexes for their activity in the ring-opening transesterification polymerization (ROTEP) of εcaprolactone (CL) was performed using a "framework distortion energy" (FDE) hypothesis. An {N,N,N,N}-aluminum complex with a bis-indolide Schiff-base ligand was predicted on the basis of that screening to be an efficient catalyst, and this prediction was tested and verified experimentally through the synthesis and characterization of the complex and evaluation of its ROTEP reactivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.